5 Biggest Biotech Trends in 2022
In Forbes' 5 Biggest Biotech Trends for 2022, top of the list is personalised medicine – of which CAR-T therapy is an outstanding example of. CAR-T therapy harnesses the power
Carina Biotech licenses German technology to create highly efficient CAR-T cells targeting hard-to-treat cancers
Carina Biotech has entered a license agreement with Bayerische Patentallianz (BayPAT) to the CXCR6-transduced CAR-T cell technology developed at the University Hospital of Ludwig-Maximillian University of Munich (LMU). The agreement
Manufacture of Carina’s LGR5 CAR-T has begun with CellVec contracted to produce GMP-grade lentivirus constructs
Singapore-based CellVec will manufacture clinical-grade lentivirus – the first critical step in making LGR5 CAR-T cells for a first-in-human clinical trial for patients with advanced colorectal (bowel) cancer in late
Carina Biotech raises $5.4 million to ready LGR5 CAR-T program for advanced colorectal cancer for the clinic
Carina Biotech is delighted to announce it has raised AU$5.4 million. The raise was strongly supported by current shareholders, board and management and attracted new institutional and impact investors including a cornerstone
Carina Biotech and AdAlta to develop unique next-generation CAR-T cancer therapeutics
Carina Biotech has entered a collaboration agreement with Melbourne biotech AdAlta to develop precision engineered, i-body enabled CAR-T therapies that provide new hope for patients with cancer. To learn more, watch
Carina researcher Jade Foeng joins Carina Biotech corporate team
We are very pleased to welcome to our corporate team Jade Foeng, researcher & PhD student in Professor Shaun McColl's lab at University of Adelaide. Jade, a researcher with Carina for 3+
Carina Biotech is pleased to announce its newly appointed Medical Advisory Board
Carina Biotech's four-member Medical Advisory Board will advise us as we prepare to take our LGR5-targeted CAR-T cell for advanced colorectal cancer into the clinic over the next 12-18 months.
Researcher in focus… Emma Thompson, PhD candidate and Carina researcher
Emma Thompson is a PhD candidate in Professor Claudine Bonder's Vascular Biology & Cell Trafficking Laboratory at UniSA's Centre for Cancer Biology. Emma's research is focused on testing Carina Biotech's LGR5-targeting CAR-T
New cancer therapy brings hope
Story by Hayden Smith, featured in The Weekend Australian, 5 June 2021 Battling blood cancer in my 20s, I put my faith in a clinical trial for a promising new
June is Bowel Cancer Awareness Month
Colorectal cancer, also known as bowel cancer, colon cancer or rectal cancer, affects men and women, young and old. Australia has one of the highest rates of colorectal cancer in